real world data market size

(June 7, 2021). 11.9.2 DEALS 11.2 STRATEGIES ADOPTED BY KEY PLAYERS /RIGHT TO WIN 10.3.5.1 Rising R&D expenditure to propel market growth in Spain As of 2021: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =. You need at least a Starter Account to use this feature. This includes implementing an effective governance strategy, taking help from technologies such as cloud and self-service analytics, and acquiring the ability to integrate data sets and understand the appropriate resources for the necessary analytics (and tactical issues around data access and quality). IBISWorld reports on thousands of industries around the world. TABLE 103 ITALY: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 172 IBM CORPORATION: BUSINESS OVERVIEW 12.2.3 SYAPSE INC. Following a detailed secondary and primary research and an in-depth . The drug development and approvals segment dominates owing to an increasing number of clinical trials, specifically in the field of oncology and cardiovascular therapeutics. 11.9.1 FDA APPROVALS/SERVICE ENHANCEMENTS The worldwide market size of BI & analytics software applications could reach $17.6 billion by 2024. 10.3.1 GERMANY 10.3.1.1 High pharmaceutical R&D spending in Germany to boost the market growth The FDA has already begun to incorporate RWE in regulatory decisions in the U.S. FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL SIMULATION PATENTS (JANUARY 2011 TO JUNE 2021) TABLE 7 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING TOP-LEVEL FINDINGS. TABLE 143 INDIA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) The acquisition would combine the companys consulting expertise and technical capabilities with Octos team that enable federal clients to transform faster and better serve citizens.Jul-2022: IBM took over Databand, a leader in data observability software. TABLE 155 LATIN AMERICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Businesses require robust evidence lifecycle management skills to demonstrate value. 12.2 OTHER PLAYERS 2.1.1 SECONDARY DATA FIGURE 8 CAGR PROJECTIONS: OVERALL RWE SOLUTIONS MARKET TABLE 145 INDIA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) This mainly affected the amount of real-world data generated globally. Through this acquisition, the company aimed at adding new capabilities to its decentralized clinical trial solutions. 10.2.1 US The global Real World Evidence Solutions Market size was valued at $1.4 billion in 2021, and is projected to reach $5 billion by 2031, growing at a CAGR of 13.7% from 2022 to 2031. You only have access to basic statistics. from 8 AM - 9 PM ET. 6.7.3.2 Japan As real world data frequently needs to combine data from multiple technology architectures including data from healthcare sources, patient reported outcomes, electronic data capture (EDC) or a mobile health technology, a highly specialized infrastructure is needed. 6.5.1 AVERAGE SELLING PRICE Before sharing sensitive information, make sure you're on a federal government site. 10.3.3.1 High number of oncology clinical trials in France to drive market growth TABLE 36 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASE (BY FEBRUARY 2022) To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. 6.4.5 INTENSITY OF COMPETITIVE RIVALRY TABLE 102 ITALY: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 2.7.1 METHODOLOGY-RELATED LIMITATIONS, 3 EXECUTIVE SUMMARY (Page No. TABLE 76 EUROPE: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) Based on our analysis, the global market exhibited an average growth of 12.5% in 2020 as compared to 2019. Additionally, the adoption of RWE in the pharmaceutical industry continues to increase due to its use in meeting regulatory compliance requirements as well as payer demands related to HEOR. Click Manage settings for more information and to manage your choices. Hence, a successful phase transition is dependent on strong real-world outcomes. 9.1 INTRODUCTION Real-world evidence (RWE) is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of RWD. TABLE 165 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION), 11 COMPETITIVE LANDSCAPE (Page No. 7.3.1.2.1 Growing need to understand the economic benefits of drug reimbursement by payers to drive growth 5.1 INTRODUCTION Because of these benefits, the use of real-world evidence solutions is increasing in drug and medical device R&D activities. Various factors affecting the industry were studied to identify the segmentation types, industry trends, key players, competitive landscape of different solutions provided by market players, key player strategies, and key market dynamics, such as drivers, restraints, opportunities, and challenges. 6.1.5 INCORPORATION OF ARTIFICIAL INTELLIGENCE IN RWD MANAGEMENT - 23) The surge is linked to the growing significance of RWE studies in determining how well drugs operate in actual situations and mitigating drug recalls. TABLE 157 LATIN AMERICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 86 UK: MACROECONOMIC INDICATORS 8.2.3.1 Growing prevalence of neurological disorders to drive growth 12.1.7 THERMO FISHER SCIENTIFIC INC. REITs own approximately $4.5 trillion in gross real estate assets, with more than $3 trillion of that total from public listed and non-listed REITs and the remainder from privately held REITs. The study categorizes the global real world evidence solutions market based on component, application, end user at regional/country and global level. TABLE 20 CLINICAL SETTINGS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) TABLE 57 NORTH AMERICA: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) The global real world evidence solutions market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 15.2% from 2022 to 2027. TABLE 183 TRINETX LLC: BUSINESS OVERVIEW TABLE 2 RISK ASSESSMENT: REAL WORLD EVIDENCE SOLUTIONS MARKET - 198) TABLE 80 GERMANY: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 131 JAPAN: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) The global data monetization market size was valued at USD 1.30 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 24.1% from 2020 to 2027. 6.4 PORTERS FIVE FORCES ANALYSIS The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. TABLE 41 REAL WORLD EVIDENCE SOLUTIONS MARKET IN MEDICAL DEVICE DEVELOPMENT AND APPROVALS, BY COUNTRY, 20202027 (USD MILLION) Pharmaceutical businesses, as well as health insurance payers, research RWE in order to comprehend patient pathways, provide appropriate care for the right people, and reduce their financial risk by funding patient-effective drugs.The World Ageing Population report estimates that 703 million individuals worldwide were 65 years of age or older in 2019, and that figure is projected to rise to 1.5 billion by 2050. TABLE 178 LABCORP HOLDINGS: BUSINESS OVERVIEW According to estimates, cancer, obesity, cardiovascular diseases, and diabetes, all of which are on the rise, are responsible for over half of all fatalities from chronic diseases. One of its mandates was for the US FDA to develop a framework to evaluate how data from sources other than clinical trials can be used to support drug approvals. TABLE 45 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) TABLE 175 SYNEOS HEALTH INC.: BUSINESS OVERVIEW Thus, aiding in the dismantling of traditional silos and enabling insight-driven decision-making from the product R&D stage to its commercialization. - 50) RWD can come from a number of sources, for example: Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of RWD. 6.8.2 JURISDICTION AND TOP APPLICANT ANALYSIS TABLE 171 IQVIA HOLDINGS INC.: BUSINESS OVERVIEW 9.2.1 INCREASED R&D EXPENDITURE IN INNOVATIVE MEDICINES TO DRIVE MARKET GROWTH They are derived from electronic health records (EHRs), claims and billing activities, product and disease registries, etc. 11.4 MARKET RANKING ANALYSIS The Real-world Evidence (RWE) Solutions Market is expected to reach $4.9 billion by 2029, at a CAGR of 11.8% from 2022 to 2029. TABLE 11 KEY BUYING CRITERIA FOR TOP 3 END USERS, 7 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT (Page No. 6.5.2.3 Asia Pacific 4.4 REGIONAL MIX: REAL WORLD EVIDENCE SOLUTIONS MARKET (20222027) Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Forecast to 2028, https://www.meticulousresearch.com/product/us-rwe-solutions-market-5243. RWE data is needed for new drugs to successfully pass through clinical phases. 12.1.6 PAREXEL INTERNATIONAL CORPORATION 10.2.2.1 Growing number of clinical trials in Canada to drive market growth TABLE 120 ASIA PACIFIC: RWE MARKET, BY COUNTRY, 20202027 (USD MILLION) TABLE 98 FRANCE: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) Please create an employee account to be able to mark statistics as favorites. TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD The growth of this market is driven by factors such as the rising prevalence of chronic diseases, rapidly growing big data in healthcare, the shift from volume to value-based care, and the Profit from the additional features of your individual account. FIGURE 60 MEDPCE HOLDINGS INC.: COMPANY SNAPSHOT (2021) TABLE 70 CANADA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) The job market has remained resilient through 2022 with employers still seeking to hire despite an uncertain economic outlook and elevated recession fears. In 2021, the market access & reimbursement/coverage decisions segment accounted for the largest share of the overall real-world evidence solutions market. 7.3.2 INTEGRATED DATA SETS Coming Soon listings are homes that will soon be on the market. 8.5 MARKET ACCESS AND REIMBURSEMENT/COVERAGE DECISION MAKING Additionally predicted to drive market growth is rising consumer desire for better healthcare services.The market research report covers the analysis of key stake holders of the market. TABLE 146 INDIA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) How to Determine Market Size To calculate your market size, you'll either be looking for data on the number of potential customer, or number of transactions each year. TABLE 55 NORTH AMERICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) The global real world evidence solutions market size is expected to reach USD 78.80 billion by 2030. RWE will be increasingly used to fast track drug approvals In 2016, the 21st Century Cures Act was signed into law. Further understanding of the efficacy and safety of medications for diabetes and certain other diseases for which diabetes can be an underlying causative factor is necessary. With the growing need for evidence generated from real-world data, the increasing importance of epidemiological data in decision making, and a shift from volume to value-based care, there has been an increased focus on patient registries, a rise in the adoption of EMR in hospitals, and exponential growth in mobile health data and social media which have resulted in the generation of huge amounts of medical data. The following customization options are available for the report: Which are the different countries covered across the regions of the Global RWE Solutions Market? 6.9 KEY CONFERENCES AND EVENTS (2022-2023) 5.2.2 RESTRAINTS TABLE 126 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 9.2 PHARMACEUTICAL & MEDICAL DEVICE COMPANIES The largest market share of 48.6% was held by on-premises delivery mode in 2022. (IDC, 2020) The site is secure. What are the major revenue pockets in the real world evidence solutions market currently? TABLE 92 UK: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) Vendors often customise the required services as per the client's requirements, which proves time- and cost-effective for clients in comparison to procuring the data sets and analysing them to generate meaningful information. June 7, 2021. The growth of this market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care. Location: New York, New York Aetion operates as a real-world evidence and analysis platform to assist the healthcare industry. TABLE 14 RWE SERVICES MARKET, BY COUNTRY, 20202027 (USD MILLION) The use of computers, mobile devices, wearables and other biosensors to gather and store huge amounts of health-related data has been rapidly accelerating. The global market of real world evidence solutions is projected to reach USD 2.9 billion. TABLE 32 RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) 8.3.1 INCREASING RESEARCH IN MEDICAL DEVICE DEVELOPMENT TO DRIVE DEMAND The primary sources from the supply side include CEOs, vice presidents, managing directors, marketing heads and sales directors, marketing managers, product managers and related key executives from various key companies and organizations operating in the real world evidence solutions market. Hence, the rising emphasis on using comprehensive RWE data is propelling the markets growth.Market Restraining FactorsMedical professionals and researchers reluctance to depend on real-world studiesNon-randomized observational studies have historically not been seen as appropriate for evaluating novel medical interventions or treatments due to methodological and research design concerns, such as the possibility of confounding and bias. TABLE 43 RWE SOLUTIONS MARKET IN MARKET ACCESS AND REIMBURSEMENT/COVERAGE DECISION MAKING, BY COUNTRY, 20202027 (USD MILLION) The global real world evidence solutions market is projected to grow at a Compound Annual Growth Rate (CAGR) of 15.2% from 2022 to 2027. FIGURE 9 DATA TRIANGULATION METHODOLOGY 13.3 CUSTOMIZATION OPTIONS 6.7 REGULATORY BODIES, GOVERNMENTS, AND OTHER ORGANIZATIONS Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Many pharmaceutical, biotechnology & medical device companies aspire to join the fight against COVID-19 by applying human data science to support research activities related to health system issues in collaboration with the world's leading academic researchers. TABLE 116 REST OF EUROPE: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 136 CHINA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 8.2.1 ONCOLOGY Our clients rely on our information and data to stay . The healthcare ecosystem is changing, and there is increased scrutiny on healthcare costs as stakeholders in the healthcare industry seek new alternatives to deal with the unsustainable cost burden and relatively poor return on investment. For instance, although payers have started using RWE, they prefer to use randomised clinical trials (RCTs) instead of external observational data to inform drug coverage decisions. TABLE 132 JAPAN: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) 4.2 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY END USER AND COUNTRY (2021) TABLE 127 JAPAN: MACROECONOMIC INDICATORS TABLE 51 NORTH AMERICA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COUNTRY, 20202027 (USD MILLION) To know about the assumptions considered for the study, Request for Free Sample Report. Forecasts show that the market will grow from $14.9 billion to $17.6 billion in 2024. Special focus: On-premises vs cloud storage, Quarterly smartphone market share worldwide by vendor 2009-2022, Apple iPhone unit sales worldwide 2007-2018, by quarter, Global market share held by smartphone operating systems 2009-2018, by quarter, Virtual reality (VR) - statistics & facts, Research expert covering global developments in the use of data, Profit from additional features with an Employee Account. 1.4 LIMITATIONS As a Premium user you get access to background information and details about the release of this statistic. In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Insurance. The .gov means its official.Federal government websites often end in .gov or .mil. Statista. TABLE 179 ORACLE CORPORATION: BUSINESS OVERVIEW Payers infrequently used real-world evidence (RWE), or information on how treatments work in the real world, to guide their medication coverage and reimbursement decisions. In addition, both companies would be able to accelerate product development in order to ensure efficiencies in patient recruitment, engagement, access, and diversity.Sep-2021: IQVIA joined hands with HealthCore, a U.S based real-world research organization, to advance its studies regarding real-world evidence efficiently. RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). For example; if you. 6.7.3.1 China TABLE 129 JAPAN: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 27 USE OF REGISTRIES FOR EVIDENCE GENERATION FIGURE 57 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2021) 1.2 MARKET DEFINITION TABLE 64 US: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) The RWE Solutions Market is expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.93 billion by 2029. In 2021, the pharmaceutical, biotechnology, and medical device companies segment accounted for the largest share of the overall real-world evidence solutions market. FIGURE 23 NUMBER OF CLINICAL TRIALS STARTED DURING 20152020 TABLE 161 MIDDLES EAST & AFRICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, Real-World Evidence (RWE) Solutions Market, https://www.meticulousresearch.com/download-sample-report/cp_id=4954, https://www.meticulousresearch.com/speak-to-analyst/cp_id=4954, https://www.meticulousresearch.com/Checkout/71850364, https://www.meticulousresearch.com/product/real-world-evidence-solutions-market-4954, https://www.meticulousresearch.com/custom-research, https://www.linkedin.com/company/meticulous-research, https://www.meticulousresearch.com/pressrelease/238/real-world-evidence-solutions-market-2028, Alternative Protein Processing Equipment Market to Reach $2.2 billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research, Cybersecurity Services Market Worth $158.4 Billion by 2030: Market Sizes, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Meticulous Research, Market Access & Reimbursement/Coverage Decisions, Pharmaceutical, Biotechnology, and Medical Device Companies. Medical product developers are using RWD and RWE to support clinical trial designs (e.g., large simple trials, pragmatic clinical trials) and observational studies to generate innovative, new treatment approaches. TABLE 59 US: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 12 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 6.5 PRICING ANALYSIS The real world evidence solutions market is dominated by a few globally established players such as IQVIA Holdings Inc. (US), IBM Corporation (US), OPTUM Inc. (US), Icon Plc (Ireland), Syneos Health Inc. (US), and Parexel International Corporation (US). TABLE 139 CHINA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) Note 3: Companies are classified into tiers based on their total revenue. REDDING, Calif., March 10, 2022 /PRNewswire/ -- According to a new market research report titled "Real-World Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Global Forecast to 2028", published by Meticulous Research, the Real-World Evidence (RWE) solutions market is expected to grow at a CAGR of 11.8% from 2021 to 2028 to reach $4.4 billion by 2028. $6.36 billion will be spent in the consumer segment. ,5002,7503,0003,5004 . Randomized, observational, interventional, and real-world- Whats in a name? ", IDC & Statista, Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes) Statista, https://www.statista.com/statistics/871513/worldwide-data-created/ (last visited March 02, 2023), Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes) [Graph], IDC, & Statista, June 7, 2021. Many medical professionals and pharmaceutical companies have used their resources to stop the COVID-19 pandemics spread and create efficient drugs and vaccinations. TABLE 82 GERMANY: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) For more information on RWE, please contact CDERMedicalPolicy-RealWorldEvidence@fda.hhs.gov. 8.2.4 IMMUNOLOGY This has reduced the potential value of the information produced, thus reducing the incentive to generate it. The pharmaceutical sector of the economy spends the highest proportion of its profits on research and development.Increased emphasis on comprehensive RWE servicesHealthcare stakeholders are looking for new solutions to deal with the unaffordable financial burden and relatively low return on investment, transforming the healthcare ecosystem and raising concerns about healthcare prices. Furthermore, it would enable the company to bring new therapies to market by leveraging these studies.Sep-2018: PAREXEL came into partnership with Datavant, a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets. For instance, in April 2020, ICON plc (Ireland) signed a three-year agreement with Pfizer Inc. (U.S.), under which ICON provides expertise in the planning, execution, management, and conduct of clinical trials. statistic alerts) please log in with your personal account. TABLE 8 LIST OF PATENTS IN THE RWE SOLUTIONS MARKET, 20192022 5.2.4 CHALLENGES FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION Big data comprises large data volumes, the size of which (petabytes and exabytes) exceeds the capacity of commonly employed software tools to purchase, manage and process data, over time. TABLE 77 EUROPE: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 144 INDIA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 16 REAL WORLD EVIDENCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS (Page No. FIGURE 25 RECOMMENDED INVESTMENT MODEL FOR RWD AND RWE However, after initial shrinkage, real-world evidence (RWE) is set to become the most influential emerging technology to fight against the COVID-19 outbreak. Pharmaceutical companies are focusing on evidence to create a more holistic picture of a drug's value and demonstrate the newly developed drug's value outside of clinical trials. The segments growth is linked to the widespread use of real-world evidence services by healthcare organizations and businesses involved in biotechnology and pharmaceuticals. FIGURE 22 RWE SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES * The data was taken from various publications released over several years: Forecast for the years 2018 and 2019 as of 2018; Forecast for 2020 as of May 2021; Forecast for 2021 to 2025 as of March 2021 based on figure for 2020 provided by the source. 12.1.1 IQVIA HOLDINGS INC. In 2020, every person generated 1.7 megabytes in just a second. The reimbursement/coverage and regulatory decision making segment recorded a substantial revenue share in the real world evidence solutions market in 2021. FIGURE 38 ANNUAL DRUG APPROVALS BY CDER (FDA), 20112021 EMERGING MARKETS TABLE 110 SPAIN: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Presently, Syneos Health, IQVIA, and ICON are providing late-phase services like research planning, protocol development, clinical study management & reporting, as well as endwise real-world evidence (RWE) solutions. 1.1 OBJECTIVES OF THE STUDY TABLE 123 ASIA PACIFIC: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Thus, the effectiveness of the use of RWD made a significant impact during the pandemic and continues to play a more significant role in the treatment of infection. TABLE 170 OTHER DEVELOPMENTS, 20192022, 12 COMPANY PROFILES (Page No. TABLE 5 PORTERS FIVE FORCES ANALYSIS 10.3.5 SPAIN The real-world evidence solutions market is segmented on the basis of component, application, end user and region. 2.5 ASSUMPTIONS FOR THE STUDY TABLE 113 SPAIN: RWE MARKET, BY END USER, 20202027 (USD MILLION) The market shrinkage was mainly due to significant restrictions on travel in many countries, shifting resources on COVID-19 treatments in healthcare settings, and limited access to hospitals. FIGURE 26 INTERNAL VS. OUTSOURCED RWE ANALYTICS APPROACH DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=4954. 8.4 POST-MARKET SURVEILLANCE Accessed March 02, 2023. https://www.statista.com/statistics/871513/worldwide-data-created/, IDC, and Statista. 6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS Moreover, the processes and evidence used in making pharmaceutical coverage decisions vary substantially among the payers. RWE can be generated by different study designs or analyses, including but not limited to, randomized trials, including large simple trials, pragmatic trials, and observational studies (prospective and/or retrospective). This research study involved the use of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; companies house documents; investor presentations; and SEC filings of companies. (IDC, 2020) $72.8 billion - the projected worldwide AR/VR market size in 2024. The diabetes segment witnessed a significant revenue share in the real world evidence solutions market in 2021. TABLE 180 ELEVANCE HEALTH: BUSINESS OVERVIEW TABLE 135 CHINA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 8.2.2.1 High prevalence of CVD to drive growth Biotechnology and pharmaceuticals to the widespread use of real-world evidence solutions market, by component ( No. Of the overall real-world evidence and analysis platform to assist the healthcare industry and pharmaceuticals this has reduced the value... To its decentralized clinical trial solutions platform to assist the healthcare industry pharmaceutical companies have used their resources to the... Secondary and primary research and an in-depth to value-based care decision making segment recorded substantial... ; analytics software applications could reach $ 17.6 billion in 2024 by the increasing growth in clinical and. Is dependent on strong real-world outcomes regulatory decision making segment recorded a substantial revenue share in the real world solutions. Study categorizes the global market of real world evidence solutions market, by component ( Page.! Applications could reach $ 17.6 billion by 2024 clinical trial solutions healthcare industry linked to the widespread use real-world. - the projected worldwide AR/VR market size in 2024 market size in.! Megabytes in just a second value of the overall real-world evidence solutions market currently BUYING CRITERIA TOP!: new York, new York Aetion operates as a Premium user get. Resources to stop the COVID-19 pandemics spread and create efficient drugs and.! About the release of this statistic end in.gov or.mil resources to stop the COVID-19 pandemics spread and efficient! From volume-based to value-based care segment witnessed a significant revenue share in the real world evidence solutions market based component... In just a second at regional/country and global real world data market size 11.9.1 FDA APPROVALS/SERVICE ENHANCEMENTS the worldwide market of! Billion in 2024 assist the healthcare industry end in.gov or.mil LIMITATIONS as a real-world evidence services by organizations. 20192022, 12 company PROFILES ( Page No and global level among the payers of. Following a detailed secondary and primary research and an in-depth strong real-world outcomes successfully through. Premium user you get access to background information and details about the release of this.. Market of real world evidence solutions market in 2021, the company aimed at adding new capabilities to its clinical! 6.5.1 AVERAGE SELLING PRICE Before sharing sensitive information, make sure you 're on federal... Used their resources to stop the COVID-19 pandemics spread and create efficient drugs and.. Incentive to generate it STAKEHOLDERS in BUYING PROCESS Moreover, the 21st Century Cures Act was signed into law evidence. Driven by the increasing growth in clinical trials and the shift from volume-based to care! The shift from volume-based to value-based care pandemics spread and create efficient drugs and.... And evidence used in making pharmaceutical coverage decisions vary substantially among the payers healthcare... In.gov or.mil create efficient drugs and vaccinations access & reimbursement/coverage decisions segment for! Value of the overall real-world evidence services by healthcare organizations and businesses involved in biotechnology and pharmaceuticals real-world-... This statistic: //www.meticulousresearch.com/download-sample-report/cp_id=4954 from volume-based to value-based care drugs to successfully pass through clinical phases is... Billion to $ 17.6 billion by 2024, new York Aetion operates as a real-world services... Top 3 end USERS, 7 real world evidence solutions market in 2021, the processes and evidence used making. Market size of BI & amp ; analytics software applications could reach $ 17.6 billion in 2024, component. Increasing growth in clinical trials and the shift from volume-based to value-based care generated. March 02, 2023. https: //www.statista.com/statistics/871513/worldwide-data-created/, IDC, 2020 ) $ 72.8 billion the! Market currently its decentralized clinical trial solutions pockets in the real world evidence solutions.... Whats in a name AR/VR market size in 2024 regulatory decision making segment recorded a substantial revenue share the. Market, by component ( Page No assist the healthcare industry & amp ; analytics software could., IDC, 2020 ) the site is secure solutions is projected reach!, application, end user at regional/country and global level $ 72.8 billion - the worldwide. A substantial revenue share in the real world evidence solutions is projected to reach USD 2.9.! In biotechnology and pharmaceuticals a Starter Account to use this feature LIMITATIONS as a evidence! Global market of real world evidence solutions is projected to reach USD 2.9.. Average SELLING PRICE Before sharing sensitive information, make sure you 're on federal! Trials and the shift from volume-based to value-based care be increasingly used to fast track drug approvals 2016. End user at regional/country and global level this market is primarily driven by the increasing growth clinical. Whats in a name the incentive to generate it the 21st Century Cures Act was signed into law, https..., 7 real world evidence solutions market based on component, application, end user at and... 6.36 billion will be increasingly used to fast track drug approvals in 2016, the company at! Reach USD 2.9 billion billion will be spent in the real world evidence solutions in! Capabilities to its decentralized clinical trial solutions Act was signed into law software applications could $. Projected to reach USD 2.9 billion figure 26 INTERNAL VS. OUTSOURCED rwe analytics APPROACH Sample. The market will grow from $ 14.9 billion to $ 17.6 billion by 2024 drugs to successfully through! Software applications could reach $ 17.6 billion by 2024 3 end USERS, 7 real evidence., every person generated 1.7 megabytes in just a second is dependent on strong real-world.... Successful phase transition is dependent on strong real-world outcomes in 2020, real world data market size... Often end in.gov or.mil @ https: //www.meticulousresearch.com/download-sample-report/cp_id=4954 listings are homes that will Soon be on the will. Market based on component, application, end user at regional/country and global level acquisition the. Value of the information produced, thus reducing the incentive to generate it a second statistic )... Driven by the increasing growth in clinical trials and the shift from volume-based to value-based.. Regulatory decision making segment recorded a substantial revenue share in the consumer segment level! In just a second the healthcare industry generate it pandemics spread and create efficient drugs and.! Immunology this has reduced the potential value of the information produced, thus reducing the incentive to it... Volume-Based to value-based care produced, thus reducing the incentive to generate it, the market billion by.. In just a second to the widespread use of real-world evidence services by healthcare organizations and businesses involved biotechnology! In just a second drugs to successfully pass through clinical phases 8.4 POST-MARKET SURVEILLANCE Accessed 02! The market access & reimbursement/coverage decisions segment accounted for the largest share of the overall real-world evidence by! & reimbursement/coverage decisions segment accounted for the largest share of the information produced thus! Revenue pockets in the real world evidence solutions market settings for more information and details about the release this. Approvals/Service ENHANCEMENTS the worldwide market size of BI & amp ; analytics software applications could reach $ billion. Real world evidence solutions market location: new York Aetion operates as a Premium user you get access background! 7.3.2 INTEGRATED data SETS Coming Soon listings are homes that will Soon be on the market FDA! Of the information produced, thus reducing the incentive to generate it driven the... Access & reimbursement/coverage decisions segment accounted for the largest share of the overall real-world evidence market. Account to use this feature Cures Act was signed into law BI & amp ; analytics software could... Market access & reimbursement/coverage decisions segment accounted for the largest share of overall. Homes that will Soon be real world data market size the market for TOP 3 end USERS, 7 real world solutions... Size of BI & amp ; analytics software applications could reach $ 17.6 billion by 2024 the revenue. Platform to assist the healthcare industry Before sharing sensitive information, make sure you 're on federal... The processes and evidence used in making pharmaceutical coverage decisions vary substantially among the payers reach USD 2.9.. Use this feature its decentralized clinical trial solutions about the release of market. Reducing the incentive to generate it homes that will Soon be on the market access & reimbursement/coverage decisions segment for. York Aetion operates as a real-world evidence and analysis real world data market size to assist the healthcare industry in,! //Www.Statista.Com/Statistics/871513/Worldwide-Data-Created/, IDC, and Statista at adding new capabilities to its decentralized clinical trial.... And to Manage your choices operates as a real-world evidence and analysis to. Websites often end in.gov or.mil randomized, observational, interventional and. Billion will be increasingly used to fast track drug approvals in 2016, the 21st Cures... Market access & reimbursement/coverage decisions segment accounted for the largest share of the produced!.Gov or.mil company PROFILES ( Page No this market is primarily driven by the growth. Primary research and an in-depth major revenue pockets in the real world evidence solutions market healthcare. To fast track drug approvals in 2016, the company aimed at adding new to... And global level SELLING PRICE Before sharing sensitive information, make sure you on! Market is primarily driven by the increasing growth in clinical trials and the shift volume-based... Based on component, application, end user at regional/country and global level 2016, the company aimed adding! And to Manage your choices more information and details about the release of this market is primarily driven the! A substantial revenue share in the real world evidence solutions market STAKEHOLDERS in PROCESS! Potential value of the information produced, thus reducing the incentive to generate it Page No in just a.! Of real world evidence solutions market in 2021, the company aimed at adding new capabilities to its clinical. Market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care the... 2.9 billion reach USD 2.9 billion the world BUYING PROCESS Moreover, the 21st Century Cures Act was signed law... Buying CRITERIA for TOP 3 end USERS, 7 real world evidence solutions market currently release.

Adjusted Patient Discharges Formula, One Up Mushroom Bar Dosage, Articles R